AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

Demodex brevis is a microscopic mite that lives in the oil glands of human hair follicles. It’s typically found on the face but can also live on other parts of the body. Demodex brevis is a type ...

This follows a successful 2024 for Tarsus, highlighted by the strong launch of XDEMVY, a treatment for Demodex blepharitis, generating over $113 million in sales. Tarsus is also pursuing ...

Send your kids to these sites to help them learn, study, indulge their curiosity, and get a fresh perspective on academic subjects. I've been contributing to PCMag since 2011 in a variety of ways ...

Fosfomycin + metronidazole is under clinical development by Reponex Pharmaceuticals and currently in Phase II for Colon Cancer. According to GlobalData, Phase II drugs for Colon Cancer have an 11% ...